Projects per year
Personal profile
Personal profile
Bincy P. Abraham, MD, MS, is an associate professor of clinical medicine in the Academic Division of Gastroenterology and Hepatology at Houston Methodist – Weill Cornell in Houston, Texas.
Dr. Abraham earned her undergraduate degree in bioengineering at Texas A&M University in College Station, and then received her medical degree from the University of Texas Medical Branch (UTMB) in Galveston. She completed her internal medicine internship and residency, as well as a gastroenterology fellowship at UTMB, where she also earned a master’s in clinical investigation and received specialized training in inflammatory bowel disease (IBD). During her training, she completed a National Visiting Fellow IBD Rotation Program through the Crohn’s and Colitis Foundation of America at Cedars-Sinai Medical Center in Los Angeles, California. She is board certified in Internal medicine and Gastroenterology. Dr. Abraham is a member of the American Gastroenterological Association, American College of Gastroenterology, Crohn’s and Colitis Foundation, American Society of Gastrointestinal Endoscopy, and chair of the South Texas Chapter of the Crohn’s and Colitis Foundation Medical Advisory Committee.
Research interests
Dr. Abraham is a principal investigator and coinvestigator in several key clinical trials. As author or coauthor, Dr. Abraham’s work has been published in peer-reviewed medical journals including Clinical Gastroenterology and Hepatology, American Journal of Gastroenterology, and Inflammatory Bowel Diseases.
External positions
Professor of Clinical Medicine, Weill Cornell Medical College
Feb 1 2016 → …
Research Area Keywords
- Digestive Disorders
- Clinical Translation & Trials
- Clinical Care
Free-text keywords
- Crohn's disease
- Pregnancy & inflammatory bowel disease
- Transition of care in inflammatory bowel disease
- Ulcerative colitis
Fingerprint
Dive into the research topics where Bincy P. Abraham is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI)
10/22/19 → …
Project: Clinical Trial
-
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2/19/19 → …
Project: Clinical Trial
-
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2/13/19 → …
Project: Clinical Trial
-
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
2/11/19 → …
Project: Clinical Trial
Research output
-
Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician
Saleh, A., Ansari, U., Abughazaleh, S., Glassner, K. & Abraham, B. P., 2022, In: Biologics: Targets and Therapy. 16, p. 67-83 17 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease
Long, M. D., Siegel, C. A., Abraham, B. P., Chiorean, M. & Mahadevan, U., Mar 2022, In: Clinical Gastroenterology and Hepatology. 20, 3, p. 706-708.e1Research output: Contribution to journal › Short survey › peer-review
1 Scopus citations -
Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)
Abraham, B., Eksteen, B., Nedd, K., Kale, H., Patel, D., Stephens, J., Shelbaya, A., Chambers, R. & Soonasra, A., May 2022, In: Advances in Therapy. 39, 5, p. 2109-2127 19 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
Alayo, Q. A., Fenster, M., Altayar, O., Glassner, K. L., Llano, E., Clark-Snustad, K., Patel, A., Kwapisz, L., Yarur, A. J., Cohen, B. L., Ciorba, M. A., Thomas, D., Lee, S. D., Loftus, E. V., Fudman, D. I., Abraham, B. P., Colombel, J. F. & Deepak, P., Jan 1 2022, In: Crohn's and Colitis 360. 4, 1, otac002.Research output: Contribution to journal › Review article › peer-review
Open Access -
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium
Shen, B., Kochhar, G. S., Rubin, D. T., Kane, S. V., Navaneethan, U., Bernstein, C. N., Cross, R. K., Sugita, A., Schairer, J., Kiran, R. P., Fleshner, P., McCormick, J. T., D'Hoore, A., Shah, S. A., Farraye, F. A., Kariv, R., Liu, X., Rosh, J., Chang, S., Scherl, E. & 17 others, , Jan 2022, In: The Lancet Gastroenterology and Hepatology. 7, 1, p. 69-95 27 p.Research output: Contribution to journal › Review article › peer-review